Similar articles

• Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P₃₈-MAPK/NF-κB/iNOS signaling pathway.

  Ali FEM, Azouz AA, Bakr AG, Abo-Youssef AM, Hemeida RAM. Ali FEM, et al. Food Chem Toxicol. 2018 Oct;120:294-304. doi: 10.1016/j.fct.2018.07.027. Epub 2018 Jul 17. Food Chem Toxicol. 2018. PMID: 30026087
• Therapeutic Potential for Modulation of Nrf2-Keap-1 Signaling Pathway as Treatment for Diabetes and Other Disorders.

  Abdel-Magid AF. Abdel-Magid AF. ACS Med Chem Lett. 2016 May 12;7(7):660-1. doi: 10.1021/acsmedchemlett.6b00181. eCollection 2016 Jul 14. ACS Med Chem Lett. 2016. PMID: 27437072 Free PMC article. No abstract available.
• 1,4-Naphthoquinone, a pro-oxidant, suppresses immune responses via KEAP-1 glutathionylation.

  Gambhir L, Checker R, Thoh M, Patwardhan RS, Sharma D, Kumar M, Sandur SK. Gambhir L, et al. Biochem Pharmacol. 2014 Mar 1;88(1):95-105. doi: 10.1016/j.bcp.2013.12.022. Epub 2014 Jan 6. Biochem Pharmacol. 2014. PMID: 24406247
• Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases.

  Zhang Y, Anoopkumar-Dukie S, Arora D, Davey AK. Zhang Y, et al. Eur J Pharmacol. 2020 Jan 15;867:172847. doi: 10.1016/j.ejphar.2019.172847. Epub 2019 Dec 5. Eur J Pharmacol. 2020. PMID: 31812544 Review.
• Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders.

  Lütjens R, Rocher JP. Lütjens R, et al. Curr Opin Pharmacol. 2017 Feb;32:91-95. doi: 10.1016/j.coph.2017.01.001. Epub 2017 Jan 27. Curr Opin Pharmacol. 2017. PMID: 28135635 Review.